Wenger Vieli advised Alturos Destinations, a provider of tourism technology solutions, on all Swiss legal and tax matters during the sale to Juniper Group. The funds will support Alturos’ growth and expand its international market reach. Wenger Vieli’s team Corporate / M&A partner Beat Speck (pictured) led the team, which comprised Barbara Brauchli Rohrer (partner, […]
On 23 May 2024, Houzy AG announced that Houzy and Devis.ch SA are merging. Walder Wyss advised Houzy Corporate/M&A with a team led by managing associates Dario Galli (pictured left) and Michael Kü
by claudia la via In 2024, the Swiss M&A landscape is predicted to see a robust recovery, marking a stark contrast from the cautious approach witnessed in 2023. As companies align with more stable economic
Kontivia Beteiligungen, a Zurich based long term oriented investment firm advised by Kellerhals Carrard, led a group of swiss entrepreneurial families, advised by Baker McKenzie, in the acquisition of a majority stake in Walter Meier (
Homburger advised Biopas on its sale to Swixx Biopharma, a swiss-based global commercial platform focusing on guaranteeing access to innovative medicines worldwide. The founders of Biopas will become shareholders of Swixx Biopharma. The transaction is
Baker McKenzie advised Arbonia on a EUR 100 million bridge loan facility regarding its acquisition of Dimoldura Group and Lignis. The facility was erogated by UBS Switzerland, which was advised by Niederer Kraft Frey (NKF).
Banking & Finance
Capital Markets
Deal & transactions
NKF for UBS Switzerland’s loan facility to Arbonia
Niederer Kraft Frey (NKF) advised UBS Switzerland on a 100 million bridge loan facility for Arbonia’s acquisition of the Dimoldura Group. Arbonia is a building components supplier listed on the SIX Swiss Exchange with annual
Bär & Karrer advises funds managed by Equistone on the sale of KWC Group’s home division, a designer and manufacturer of kitchen, bathroom and washroom fittings and accessories, to Paini Rubinetterie. Bär &
Advestra advised Cactus life sciences, a global scientific communications agency that works with blue chip pharma and biotechnology companies, on nspm and eluSCIdate’
Walder Wyss, together with CastaldiPartners, advised Provost on its acquisition of Mino & Lorenzini. Walder Wyss’ team comprised corporate and M&A partner Luc Defferrard (pictured) and corporate / M&A associate Ken Savioz.
